Skip to main content

Table 4 Multivariable model to examine whether diabetes is an independent predictor of 90-day mortality in patients with Middle East Respiratory Syndrome (MERS). We adjusted for age, sex, asthma or chronic pulmonary disease, chronic neurological disease, immunosuppressant use before admission, body mass index (BMI), and SOFA score. Model I: Complete case analysis with no imputation (participants with any missing data are excluded). Model II: Multiple imputation (participants with missing data identified and replaced)

From: Critically ill patients with diabetes and Middle East respiratory syndrome: a multi-center observational study

Variables Model I (N = 266) Model II (N = 350)
OR (95% CI) P-value OR (95% CI) P-value
Diabetes 2.09 (1.18, 3.72) 0.005 2.13 (1.15, 3.95) 0.02
SOFA (per one-unit increase) 1.20 (1.14, 1.26) < 0.0001 1.17 (1.12, 1.23) < 0.0001
Female sex 1.68 (1.06, 2.67) 0.02 1.74 (1.09, 2.79) 0.02
Age (per one-year increase) 1.04 (1.02, 1.06) 0.0002 1.04 (1.02, 1.06) < 0.0001
Chronic neurological disease 3.07 (0.80, 11.81) 0.07 3.40 (1.04, 11.14) 0.04
BMI (kg/m2) (per one-unit increase) 0.97 (0.90, 1.03) 0.23 0.96 (0.91, 1.02) 0.21
Immunosuppressant use before admission 1.24 (0.29, 5.26) 0.74 1.13 (0.35, 3.64) 0.84
Asthma or chronic pulmonary disease 1.20 (0.66, 2.20) 0.51 1.04 (0.57, 1.91) 0.90
  1. OR Odds Ratio, CI Confidence Interval, BMI body mass index, SOFA Sequential Organ Failure Assessment